95 related articles for article (PubMed ID: 12854884)
21. Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control study.
Weinbrenner T; Zittermann A; Gouni-Berthold I; Stehle P; Berthold HK
Eur J Clin Nutr; 2003 Oct; 57(10):1262-7. PubMed ID: 14506487
[TBL] [Abstract][Full Text] [Related]
22. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Bone resorption marker; urinary and serum CTX].
Gorai I
Clin Calcium; 2006 Jun; 16(6):1001-8. PubMed ID: 16751697
[TBL] [Abstract][Full Text] [Related]
23. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
Verit FF; Geyikli I; Yazgan P; Celik A
Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
[TBL] [Abstract][Full Text] [Related]
24. Early elevation in circulating levels of C-telopeptides of type II collagen predicts structural damage in articular cartilage in the rodent model of collagen-induced arthritis.
Oestergaard S; Chouinard L; Doyle N; Smith SY; Tankó LB; Qvist P
Arthritis Rheum; 2006 Sep; 54(9):2886-90. PubMed ID: 16947421
[TBL] [Abstract][Full Text] [Related]
25. Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study.
Martínez J; Olmos JM; Hernández JL; Pinedo G; Llorca J; Obregón E; Valero C; González-Macías J
Clin Chim Acta; 2009 Nov; 409(1-2):70-4. PubMed ID: 19737549
[TBL] [Abstract][Full Text] [Related]
26. Biochemical markers of bone turnover in diagnosis of myeloma bone disease.
Dizdar O; Barista I; Kalyoncu U; Karadag O; Hascelik G; Cila A; Pinar A; Celik I; Kars A; Tekuzman G
Am J Hematol; 2007 Mar; 82(3):185-91. PubMed ID: 17022050
[TBL] [Abstract][Full Text] [Related]
27. Reduced attenuation of bone resorption after oral glucose in type 2 diabetes.
Chailurkit LO; Chanprasertyothin S; Rajatanavin R; Ongphiphadhanakul B
Clin Endocrinol (Oxf); 2008 Jun; 68(6):858-62. PubMed ID: 18088395
[TBL] [Abstract][Full Text] [Related]
28. Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women.
Alexandersen P; Karsdal MA; Qvist P; Reginster JY; Christiansen C
Bone; 2007 Jan; 40(1):218-22. PubMed ID: 17010685
[TBL] [Abstract][Full Text] [Related]
29. Effect of bed rest during pregnancy on bone turnover markers in pregnant and postpartum women.
Kaji T; Yasui T; Suto M; Mitani R; Morine M; Uemura H; Maeda K; Irahara M
Bone; 2007 Apr; 40(4):1088-94. PubMed ID: 17229597
[TBL] [Abstract][Full Text] [Related]
30. Serum and plasma fragments of C-telopeptides of type I collagen (CTX) are stable during storage at low temperatures for 3 years.
Qvist P; Munk M; Hoyle N; Christiansen C
Clin Chim Acta; 2004 Dec; 350(1-2):167-73. PubMed ID: 15530474
[TBL] [Abstract][Full Text] [Related]
31. Effects of short-term risedronate on bone resorption and patient satisfaction in postmenopausal osteoporosis patients.
Fernandes CE; Zerbini C; Russo LA; Albernaz MA; Eis SR; Szejnfeld VL; Pompei LM
J Clin Densitom; 2009; 12(1):77-83. PubMed ID: 19004654
[TBL] [Abstract][Full Text] [Related]
32. Telopeptides as markers of bone turnover in rheumatoid arthritis and osteoarthritis.
Wong PK; Young L; Vaile JH; Tan L; Bertouch JV; Bleasel JF; White C
Intern Med J; 2004; 34(9-10):539-44. PubMed ID: 15482266
[TBL] [Abstract][Full Text] [Related]
33. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
[TBL] [Abstract][Full Text] [Related]
34. Serological markers of erosive hand osteoarthritis.
Ramonda R; Lorenzin M; Modesti V; Campana C; Ortolan A; Frallonardo P; Punzi L
Eur J Intern Med; 2013 Jan; 24(1):11-5. PubMed ID: 23102569
[TBL] [Abstract][Full Text] [Related]
35. Coll2-1, Coll2-1NO2 and myeloperoxidase serum levels in erosive and non-erosive osteoarthritis of the hands.
Punzi L; Ramonda R; Deberg M; Frallonardo P; Campana C; Musacchio E; Henrotin Y
Osteoarthritis Cartilage; 2012 Jun; 20(6):557-61. PubMed ID: 22401873
[TBL] [Abstract][Full Text] [Related]
36. Galactosaminoglycuronglycan sulfate in erosive osteoarthritis of the hands: early diagnosis, early treatment.
Rovetta G; Monteforte P
Int J Tissue React; 1996; 18(1):43-6. PubMed ID: 8880379
[TBL] [Abstract][Full Text] [Related]
37. Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis.
Garnero P; Conrozier T; Christgau S; Mathieu P; Delmas PD; Vignon E
Ann Rheum Dis; 2003 Oct; 62(10):939-43. PubMed ID: 12972471
[TBL] [Abstract][Full Text] [Related]
38. [Research progress of C terminal propeptide of collagen type II].
Bai L; Wang Y; Ba G
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jan; 25(1):66-9. PubMed ID: 21351613
[TBL] [Abstract][Full Text] [Related]
39. The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnover.
Bay-Jensen AC; Tabassi NC; Sondergaard LV; Andersen TL; Dagnaes-Hansen F; Garnero P; Kassem M; Delaissé JM
Arthritis Res Ther; 2009; 11(1):R9. PubMed ID: 20527083
[TBL] [Abstract][Full Text] [Related]
40. Joint failure in erosive osteoarthritis of the hands.
Rovetta G; Bianchi G; Monteforte P
Int J Tissue React; 1995; 17(1):33-42. PubMed ID: 7499062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
